C07D 471/22
In which the condensed systems contains four or more hetero rings
Official title: in which the condensed systems contains four or more hetero rings
C07D471/22 (In which the condensed systems contains four or more hetero rings) appears on 523 US grants and 682 published applications in this corpus.
Search patents in C07D- Granted patents
- 523
- Published applications
- 682
- Assignees
- 348
- Inventors
- 1,851
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 5 | 0 |
| 1978 | 5 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 5 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 1 |
| 2002 | 3 | 5 |
| 2003 | 6 | 8 |
| 2004 | 4 | 10 |
| 2005 | 2 | 1 |
| 2006 | 6 | 8 |
| 2007 | 5 | 12 |
| 2008 | 5 | 8 |
| 2009 | 6 | 17 |
| 2010 | 5 | 16 |
| 2011 | 8 | 24 |
| 2012 | 11 | 24 |
| 2013 | 13 | 36 |
| 2014 | 25 | 38 |
| 2015 | 36 | 39 |
| 2016 | 37 | 37 |
| 2017 | 36 | 53 |
| 2018 | 32 | 25 |
| 2019 | 21 | 42 |
| 2020 | 22 | 30 |
| 2021 | 29 | 35 |
| 2022 | 20 | 41 |
| 2023 | 20 | 51 |
| 2024 | 52 | 36 |
| 2025 | 31 | 52 |
| 2026 | 22 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- MALT-1 modulators8 Sep 2026US 12,729,201 B2Recursion Pharmaceuticals, Inc.
- Ring-in-ring complexes exhibiting tunable multicolor photoluminescence4 Aug 2026US 12,698,285 B2Northwestern University
- Tetrahydroisoquinoline derivatives for the treatment of red blood disorders and inflammatory diseases28 Jul 2026US 12,692,274 B2Sanofi
- Aroyl substituted tricyclic compound, preparation method therefor and use thereof28 Jul 2026US 12,692,275 B2Genfleet Therapeutics (Shanghai) Inc.
- Polycyclic compounds for organic electroluminescent devices30 Jun 2026US 12,668,601 B2UDC Ireland Limited
- Anti-inflammatory compounds, pharmaceutical compositions, and methods of treating hemochromatosis and other disorders8 Oct 2026US 2026/0308181 A1Miralogx LLC
- Azepino Analogs and Methods of Making and Using the Same24 Sep 2026US 2026/0284073 A1Kuleon LLC
- Small molecule glp-1 agonists24 Sep 2026US 2026/0285878 A1Ambrosia Biosciences Inc.
- Sik2 modulators and uses thereof17 Sep 2026US 2026/0274820 A1Nimbus Salacia, Inc.
- Substituted tricyclic compounds as fgfr inhibitors3 Sep 2026US 2026/0258042 A1Incyte Corporation
Most cited
By later US patents
- Rigidized trimethine cyanine dyes103US 6,133,445 ACarnegie Mellon University · 2000
- Azepine inhibitors of Janus kinases92US 8,563,541 B2Incyte Corporation · 2013
- Macrocyclic compounds as Trk kinase inhibitors83US 8,933,084 B2Array BioPharma Inc. · 2015
- Azepine inhibitors of janus kinases72US 8,835,423 B2Incyte Corporation · 2014
- Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors70US 8,791,123 B2Array BioPharma Inc. · 2014